Search research articles
Contact Us
Filters
Showing results (161-170 of 228) with videos related to
Page
of 23
Sort By:
Cancer Treatment Reviews
|
December 19, 2012
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations
Carmine Pinto, Silvia Novello, Valter Torri, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2023
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study
Giorgio Bogani, Michela Cinquini, Diego Signorelli, et al.
Cancer Cell
|
May 20, 2020
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
Jennifer G Whisenant, Annalisa Trama, Valter Torri, et al.
The Lancet. Oncology
|
December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
Thierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
Gynecologic Oncology
|
January 22, 2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer
Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, et al.
Cancer Immunology Research
|
February 27, 2019
Combined Low Densities of FoxP3<sup>+</sup> and CD3<sup>+</sup> Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression
Tommaso Cavalleri, Paolo Bianchi, Gianluca Basso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
Jacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 19, 2010
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis
Marina Chiara Garassino, Valter Torri, Giovanni Michetti, et al.
British Journal of Cancer
|
September 21, 2019
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer
Nicoletta Colombo, Eleonora Zaccarelli, Alessandra Baldoni, et al.
Clinical Colorectal Cancer
|
February 23, 2023
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial)
Carlo Sposito, Filippo Pietrantonio, Marianna Maspero, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 228) with videos related to
Sort By:
Page
of 23
Cancer Treatment Reviews
|
December 19, 2012
Second Italian consensus conference on malignant pleural mesothelioma: state of the art and recommendations
Carmine Pinto, Silvia Novello, Valter Torri, et al.
Critical Reviews in Oncology/Hematology
|
May 8, 2023
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study
Giorgio Bogani, Michela Cinquini, Diego Signorelli, et al.
Cancer Cell
|
May 20, 2020
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
Jennifer G Whisenant, Annalisa Trama, Valter Torri, et al.
The Lancet. Oncology
|
December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials
Thierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
Gynecologic Oncology
|
January 22, 2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer
Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, et al.
Cancer Immunology Research
|
February 27, 2019
Combined Low Densities of FoxP3<sup>+</sup> and CD3<sup>+</sup> Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression
Tommaso Cavalleri, Paolo Bianchi, Gianluca Basso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
Jacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 19, 2010
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis
Marina Chiara Garassino, Valter Torri, Giovanni Michetti, et al.
British Journal of Cancer
|
September 21, 2019
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer
Nicoletta Colombo, Eleonora Zaccarelli, Alessandra Baldoni, et al.
Clinical Colorectal Cancer
|
February 23, 2023
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial)
Carlo Sposito, Filippo Pietrantonio, Marianna Maspero, et al.
Page
of 23